Envincio, LLC – Trademark Portfolio

Entity Type: 16

Envincio, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include PBO-8, ENVINCIO, and ESSENTRIA. The owner is based in CARY, NC.

SUITE 101

200 CASCADE POINTE

CARY, NC 27513

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ESSENTRIA
ESSENTRIA
Registered 2011
ENVINCIO
ENVINCIO
Registered 2010
ENVINCIO
ENVINCIO
Registered 2010
PBO-8
PBO-8
Registered 1983

Trademark Classifications

Envincio, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Envincio, LLC have?

Envincio, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Envincio, LLC file in?

Envincio, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Envincio, LLC's most well-known trademarks?

Envincio, LLC's registered trademark portfolio includes well-known marks such as PBO-8, ENVINCIO, and ESSENTRIA. These are among 4 currently registered trademarks in the portfolio.

What is Envincio, LLC's trademark registration success rate?

Envincio, LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.